TP53 and neoplasm: Indeed, cancers often lose epithelial markers (for example, E-cadherin, p53, and RB) and exhibit mesenchymal markers such as Vimentin, N-cadherin and Fascin1 (see Fig. 1) before becoming invasive or circulating tumor cells (CTCs), hence facilitating tumor spread.